{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T19:39:56Z","timestamp":1770665996039,"version":"3.49.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,12,5]],"date-time":"2014-12-05T00:00:00Z","timestamp":1417737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1007\/s11255-014-0890-z","type":"journal-article","created":{"date-parts":[[2014,12,4]],"date-time":"2014-12-04T08:59:05Z","timestamp":1417683545000},"page":"521-525","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Intravenous magnesium sulfate: new method in prevention of contrast-induced nephropathy in primary percutaneous coronary intervention"],"prefix":"10.1007","volume":"47","author":[{"given":"Ata","family":"Firouzi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Maadani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Kiani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshad","family":"Shakerian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid Reza","family":"Sanati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Zahedmehr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyedabbas","family":"Nabavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona","family":"Heidarali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,5]]},"reference":[{"key":"890_CR1","unstructured":"McCullough P (2007) Renal complication of contrast media. In: King Spencer B interventional cardiology, 1st edn, chapter 23, McGraw-Hill, China"},{"issue":"9","key":"890_CR2","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1001\/jama.300.9.1038","volume":"300","author":"SS Brar","year":"2008","unstructured":"Brar SS, Shen AYJ, Jorgensen MB, Kotlewski A, Aharonian VJ, Desai N et al (2008) Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography. A randomized trial. JAMA 300(9):1038\u20131046","journal-title":"JAMA"},{"key":"890_CR3","first-page":"985","volume":"19","author":"J Roozbeh","year":"2008","unstructured":"Roozbeh J, Jahromi AH, Sharifian M, Pakfetrat M, Afsharinia R (2008) Protective effect of pentoxifylline on contrast induced nephropathy, Saudi. J Kidney Dis Transpl 19:985\u2013986","journal-title":"J Kidney Dis Transpl"},{"issue":"10","key":"890_CR4","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1093\/ndt\/gfp306","volume":"24","author":"F Ferrario","year":"2009","unstructured":"Ferrario F, Barone MT, Landoni G, Genderini A, Heidemperger M, Trezzi M et al (2009) Acetylcysteine and non-ionic isosmolar contrast-induced nephropathy\u2014a randomized controlled study. Nephrol Dial Transpl 24(10):3103\u20133107","journal-title":"Nephrol Dial Transpl"},{"key":"890_CR5","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/hrt.2004.039636","volume":"91","author":"VO Gomes","year":"2005","unstructured":"Gomes VO, Poli CE, Figueredo DE, Caramori P, Lasevitch R, Bodanese LC, Araujol A et al (2005) N-acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial. Heart 91:774\u2013778","journal-title":"Heart"},{"key":"890_CR6","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1148\/radiol.2393041456","volume":"239","author":"W Huber","year":"2006","unstructured":"Huber W, Hennig M, Rosenbrock H, Wacker A, Saur D (2006) Prophylaxis of contrast material\u2014induced nephropathy in patients in intensive care: acetylcysteine, theophylline, or both? A randomized study. Radiology 239:793\u2013804","journal-title":"Radiology"},{"key":"890_CR7","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1745-6215-10-45","volume":"10","author":"M Amini","year":"2009","unstructured":"Amini M, Salarifar M, Amirbaigloo A, Masoudkabi F, Esfahani F (2009) N-acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial. Trials 10:45","journal-title":"Trials"},{"issue":"3","key":"890_CR8","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ahj.2008.11.010","volume":"157","author":"SH Jo","year":"2009","unstructured":"Jo SH, Koo BK, Park JS, Kang HJ, Kim YJ, Kim HL et al (2009) N-acetylcysteine versus ascorbic acid for preventing contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study\u2014a prospective randomized controlled trial. Am Heart J 157(3):576\u2013583","journal-title":"Am Heart J"},{"issue":"3","key":"890_CR9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ijcard.2005.06.038","volume":"109","author":"TM Ng","year":"2006","unstructured":"Ng TM, Shurmur SW, Silver M, Nissen LR, O\u2019Leary EL, Rigmaiden RS, Cieciorka M et al (2006) Comparison of N-acetylcysteine and fenoldopam for preventing contrast-induced nephropathy (CAFCIN). Int J Cardiol 109(3):322\u2013328","journal-title":"Int J Cardiol"},{"issue":"4","key":"890_CR10","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.jacc.2004.04.052","volume":"44","author":"C Briguori","year":"2004","unstructured":"Briguori C, Colombo A, Airoldi F, Violante A, Castelli A, Balestrieri P et al (2004) N-acetylcysteine versus fenoldopammesylate to prevent contrast agent-associated nephrotoxicity. J Am Coll Cardiol 44(4):762\u2013765","journal-title":"J Am Coll Cardiol"},{"key":"890_CR11","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1001\/archinte.165.10.1087","volume":"165","author":"SM Bagshaw","year":"2005","unstructured":"Bagshaw SM, Ghali WA (2005) Theophylline for prevention of contrast-induced nephropathy. Arch Intern Med 165:1087\u20131093","journal-title":"Arch Intern Med"},{"issue":"11","key":"890_CR12","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1093\/ndt\/17.11.1936","volume":"17","author":"A Kapoor","year":"2002","unstructured":"Kapoor A, Kumar S, Gulati S, Gambhir S, Sethi RS, Sinha N (2002) The role of theophylline in contrast-induced nephropathy: a case-control study. Nephrol Dial Transpl 17(11):1936\u20131941","journal-title":"Nephrol Dial Transpl"},{"issue":"12","key":"890_CR13","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1592\/phco.23.15.1617.31958","volume":"23","author":"PD Walker","year":"2003","unstructured":"Walker PD, Brokering KL, Theobald JC (2003) Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy: a review. Pharmacotherapy 23(12):1617\u20131626","journal-title":"Pharmacotherapy"},{"key":"890_CR14","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1001\/jama.291.19.2328","volume":"291","author":"GJ Merten","year":"2004","unstructured":"Merten GJ, Burgess WP, Gray LV, Holleman JH, Roush TS et al (2004) Prevention of contrast-induced nephropathy with sodium bicarbonate. A randomized controlled trial. JAMA 291:2328\u20132334","journal-title":"JAMA"},{"issue":"3","key":"890_CR15","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s11255-009-9569-2","volume":"41","author":"M Kanbay","year":"2009","unstructured":"Kanbay M, Covic A, Coca SG, Turgut F, Akcay A, Parikh CR (2009) Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials. Int Urol Nephrol 41(3):617\u2013627","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"890_CR16","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/ndt\/gfu025","volume":"29","author":"J Kooiman","year":"2014","unstructured":"Kooiman J, Sijpkens YW, de Vries JP, Brulez HF, Hamming JF, van der Molen AJ, Aarts NJ, Cannegieter SC, Putter H, Swarts R, van den Hout WB, Rabelink TJ, Huisman MV (2014) A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography. Nephrol Dial Transpl 29(5):1029\u20131036","journal-title":"Nephrol Dial Transpl"},{"key":"890_CR17","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1161\/01.CIR.0000146396.19081.73","volume":"110","author":"K Spargias","year":"2004","unstructured":"Spargias K, Alexopoulos E, Kyrzopoulos S, Iacovis P, Greenwood DC, Manginas A et al (2004) Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation 110:2837\u20132842","journal-title":"Circulation"},{"issue":"5","key":"890_CR18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.5414\/CNP68279","volume":"68","author":"A Boscheri","year":"2007","unstructured":"Boscheri A, Weinbrenner C, Botzek B, Reynen K, Kuhlisch E, Strasser RH (2007) Failure of ascorbic acid to prevent contrast-media induced nephropathy in patients with renal dysfunction. Clin Nephrol 68(5):279\u2013286","journal-title":"Clin Nephrol"},{"key":"890_CR19","doi-asserted-by":"crossref","unstructured":"Abizaid AS, Clark CE, Mintz GS, Dosa S, Popma JJ, Pichard AD et al (1999) Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. Am J Cardiol 83(2):260\u2013263, A5","DOI":"10.1016\/S0002-9149(98)00833-9"},{"issue":"9","key":"890_CR20","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/BF02044112","volume":"22","author":"T Staudinger","year":"1996","unstructured":"Staudinger T, Presterl E, Graninger W, Locker GJ, Knapp S et al (1996) Influence of pentoxifylline on cytokine levels and inflammatory parameters in septic shock. Intensive Care Med 22(9):888\u2013893","journal-title":"Intensive Care Med"},{"key":"890_CR21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1053\/ajkd.1998.v32.pm9669426","volume":"32","author":"RE Katholi","year":"1998","unstructured":"Katholi RE, Woods WT Jr, Taylor GJ, Deitrick CL, Womack KA, Katholi CR, McCann WP (1998) Oxygen free radicals and contrast nephropathy. Am J Kidney Dis 32:64\u201371","journal-title":"Am J Kidney Dis"},{"key":"890_CR22","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1046\/j.1523-1755.2002.00673.x","volume":"62","author":"JD Durham","year":"2002","unstructured":"Durham JD, Caputo C, Dokko J, Zaharakis T, Pahlavan M, Keltz J, Dutka P, Marzo K, Maesaka JK, Fishbane S (2002) A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography. Kidney Int 62:2202\u20132207","journal-title":"Kidney Int"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-014-0890-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-014-0890-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-014-0890-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T04:13:49Z","timestamp":1566101629000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-014-0890-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,5]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["890"],"URL":"https:\/\/doi.org\/10.1007\/s11255-014-0890-z","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,5]]}}}